Breadcrumb

Breadcrumbs

Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Journalists may direct questions to mediainquiries@dsi.com. Or click here for direct contact information for Daiichi Sankyo U.S. Public Affairs team

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Wed Apr 04 00:00:00 GMT-04:00 2018
Daiichi Sankyo and DarwinHealth Enter Exclusive Research Collaboration for Novel Cancer Target Init ...
PDF (201 KB)
Tue Mar 27 00:00:00 GMT-04:00 2018
Daiichi Sankyo, Inc. and the Crohn’s & Colitis Foundation Launch Get Iron Informed
PDF (226 KB)
Tue Mar 27 00:00:00 GMT-04:00 2018
Daiichi Sankyo's HER2-Targeting Antibody Drug Conjugate DS-8201 Receives SAKIGAKE Designation for G ...
PDF (51 KB)
Wed Mar 07 00:00:00 GMT-04:00 2018
Daiichi Sankyo Initiates Phase 2 Study of DS-8201 in Patients with HER2-Expressing Advanced Colorec ...
PDF (213 KB)
Wed Feb 28 00:00:00 GMT-04:00 2018
Daiichi Sankyo, Inc. Aligns U.S. Commercial Operations to Current Portfolio and Upcoming Cancer Pip ...
PDF (148 KB)
Thu Feb 22 00:00:00 GMT-04:00 2018
Daiichi Sankyo Initiates Phase 1 Study of DS-1062 in Patients with Advanced Non-Small Cell Lung Can ...
PDF (181 KB)
Tue Feb 06 00:00:00 GMT-04:00 2018
Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Smal ...
PDF (180 KB)
Thu Jan 18 00:00:00 GMT-04:00 2018
Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer at ...
PDF (271 KB)
Tue Dec 12 00:00:00 GMT-04:00 2017
​​​​​​​Once-Daily, Oral SAVAYSA® (edoxaban) Met Primary Endpoint in Investigational Hokusai-VTE CAN ...
PDF (230 KB)
Tue Dec 12 00:00:00 GMT-04:00 2017
Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in H ...
PDF (215 KB)
Showing 11 - 20 of 47 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...